3D printing (3DP) of pharmaceutical formulations via commercially available FDM printers has gained interested in recent years, enabling personalisation of medicines. It also facilitates advanced control of the micro-structure of the tablet core, permitting fine tuning of product release characteristics with a single formulation. In addition, the technology also offers a platform for Dose escalation studies employing a single formulation and single manufacturing step. The objective of this study was to develop a mechanical properties screening tool and quality control test for pharmaceutically relevant feedstock material for FDM
Fused Deposition Modelling (FDM) is a variant of 3D Printing (3DP) that relies on the melt extrusion...
This study aims to investigate the variation of the 3D printers Ultimaker 3 and ZMorph VX by printin...
Abstract of the communication presented at the Controlled Release Society Virtual Annual Meeting, 29...
3D printing (3DP) of pharmaceutical formulations via commercially available FDM printers has gained ...
Purpose: The filament-based feeding mechanism employed by the majority of fused deposition modelling...
3D printing (3DP) of pharmaceutical formulations via commercially available FDM pinters has gained i...
3D printing (3DP) of pharmaceutical formulations via commercially available FDM printers has gained ...
Fused deposition modeling (FDM) 3D printing is being increasingly explored as a direct manufacturing...
The two major drawbacks of filament based material extrusion printing in pharmaceutical manufacturin...
3d printing is capable of providing dose individualization for pediatric medicines and translating t...
Linking a hot-melt-extrusion (HME) process to 3D printing offers the ability for rapid prototyping o...
Three-dimensional printing (3DP) provides a flexible and cost-beneficial solution to patient-centric...
Poster presented at the PSWC2020 Virtual (7th FIP Pharmaceutical Sciences World Congress), 4-6 Octob...
Purpose With the recent FDA approval of the first 3D printed tablet, there seems to be a gradual shi...
The present study aimed to analyze how the printing process affects the final state of a printed pha...
Fused Deposition Modelling (FDM) is a variant of 3D Printing (3DP) that relies on the melt extrusion...
This study aims to investigate the variation of the 3D printers Ultimaker 3 and ZMorph VX by printin...
Abstract of the communication presented at the Controlled Release Society Virtual Annual Meeting, 29...
3D printing (3DP) of pharmaceutical formulations via commercially available FDM printers has gained ...
Purpose: The filament-based feeding mechanism employed by the majority of fused deposition modelling...
3D printing (3DP) of pharmaceutical formulations via commercially available FDM pinters has gained i...
3D printing (3DP) of pharmaceutical formulations via commercially available FDM printers has gained ...
Fused deposition modeling (FDM) 3D printing is being increasingly explored as a direct manufacturing...
The two major drawbacks of filament based material extrusion printing in pharmaceutical manufacturin...
3d printing is capable of providing dose individualization for pediatric medicines and translating t...
Linking a hot-melt-extrusion (HME) process to 3D printing offers the ability for rapid prototyping o...
Three-dimensional printing (3DP) provides a flexible and cost-beneficial solution to patient-centric...
Poster presented at the PSWC2020 Virtual (7th FIP Pharmaceutical Sciences World Congress), 4-6 Octob...
Purpose With the recent FDA approval of the first 3D printed tablet, there seems to be a gradual shi...
The present study aimed to analyze how the printing process affects the final state of a printed pha...
Fused Deposition Modelling (FDM) is a variant of 3D Printing (3DP) that relies on the melt extrusion...
This study aims to investigate the variation of the 3D printers Ultimaker 3 and ZMorph VX by printin...
Abstract of the communication presented at the Controlled Release Society Virtual Annual Meeting, 29...